Based on these results, we conclude that among DMCs, only replication-quiescent MeSCs are capable of long-term survival in vivo and that the GM-CSF-stimulated immune system, which appears to effectively prevent the formation of primary tumours, is ineffective in eradicating these dormant/quiescent MeSCs. Here, CSF2 is linked to neoplasm.